Liminatus Pharma, Inc. (LIMNW) stock
LIMNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMN
$0.04+0.00 (0.00%)
Close on Oct 30, 2026Market cap $189.39MP/E –Yield –
Liminatus Pharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Liminatus Pharma's market cap was $174.07M on Oct 19, 2026, against $1.81B a year earlier.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $174.07M | -78.9% |
| 2025 | Dec 31, 2025 | $825.47M | – |